From Data to Daily Practice; Disrupting Calcium with IVL across multiple vessel beds.
Welcome to The Catalyst
Change isn't quick. Unless it's when you experience Intravascular Lithotripsy (IVL) for the first time. Stay apprised of our latest news and insights while discovering how a simple and intuitive tool can be The Catalyst to change the way you think about calcium modification.
Welcome to ChalkTalk, our new podcast series where we discuss all things cardiovascular calcium, featuring perspective from our leaders and leading physicians who are using IVL in clinical practice to crack their toughest cases. We plan to bring you the latest cases, insights & evidence surrounding both coronary and peripheral Shockwave IVL.
Your first Shockwave IVL newsletter, PulsePoint, has arrived. We’re kicking off with an ambitious recap of 2020, celebrating key milestones and major events for our customers using our peripheral technology across the globe. Released on a quarterly basis moving forward, PulsePoint will be the one stop shop for all the latest news and updates throughout the year. We hope you enjoy our first global edition of PulsePoint.
The treatment of calcified below-the-knee (BTK) lesions is challenging, associated with sub-optimal procedural outcomes, resulting in early recoil, and may contribute to restenosis.
Following the excitement of the PAD III RCT results presented at VIVA in November, a rock star faculty of Prof. Gunnar Tepe, Prof. Thomas Zeller, Dr. Arne Schwindt and Dr. Lorenzo Patrone assembled for an incathlab session to discuss the study results and how IVL offers superior vessel preparation over conventional PTA in severely calcified PAD lesions.
At the recent PCR Valves eCourse (aka London Valves), an esteemed faculty reported on the use of IVL- facilitated TAVI. Profs./Drs. Carlo Di Mario, Ole De Backer, Joachim Schofer, Constantin von zur Mühlen used published data and case experiences to illustrate the advantages of using IVL to maintain transfemoral access in TAVI patients with severely calcified iliacs. Considering the importance of reducing complications to minimize hospital stay, the faculty expressed enthusiasm when considering the use of IVL in these very complex patients. Happy viewing!
In life, and when treating patients, we all prefer things to be less complicated. Unfortunately, treating peripheral vascular calcification is typically associated with suboptimal vessel expansion and an increased risk of complications.
In DISRUPT PAD III, we included the complex, torturous, calcified lesions and risky patients that other studies avoid. Review the results for yourself and see what superior looks like.
Dr. Nathan Aranson is a vascular surgeon at Maine Medical Center in Portland, Maine. He shares with us his experience using IVL for aortoiliac occlusive disease (AIOD).